ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
60.910,36
0,19%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. QuidelOrtho Corporation (QDEL)

  7. QuidelOrtho Corporation (QDEL) News

QDEL

QuidelOrtho (QDEL)

QuidelOrtho Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:QDEL
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202411h45PR Newswire (US)Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact The Gross Law Firm Before June 11, 2024 to Discuss Your Rights - QDELNASDAQ:QDELQuidelOrtho Corporation
08/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
08/05/202422h05Business WireQuidelOrtho Reports First Quarter 2024 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
07/05/202422h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
07/05/202412h05PR Newswire (US)Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact The Gross Law Firm about pending Class Action - QDELNASDAQ:QDELQuidelOrtho Corporation
03/05/202411h45PR Newswire (US)Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:QDELQuidelOrtho Corporation
02/05/202414h00Business WireQuidelOrtho Appoints Brian J. Blaser as President and Chief Executive OfficerNASDAQ:QDELQuidelOrtho Corporation
26/04/202411h45PR Newswire (US)QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDELNASDAQ:QDELQuidelOrtho Corporation
19/04/202412h40PR Newswire (US)Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:QDELQuidelOrtho Corporation
17/04/202413h00Business WireQuidelOrtho To Report First Quarter 2024 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
10/04/202413h00Business WireQuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership AssayNASDAQ:QDELQuidelOrtho Corporation
02/04/202415h00Business WireQuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 TestNASDAQ:QDELQuidelOrtho Corporation
06/03/202422h35Business WireQuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in CanadaNASDAQ:QDELQuidelOrtho Corporation
29/02/202422h40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QDELQuidelOrtho Corporation
29/02/202421h29Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QDELQuidelOrtho Corporation
26/02/202422h30Business WireQuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor ConferenceNASDAQ:QDELQuidelOrtho Corporation
21/02/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
21/02/202413h30Business WireQuidelOrtho Announces Changes in Executive LeadershipNASDAQ:QDELQuidelOrtho Corporation
16/02/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
16/02/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
16/02/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
13/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
13/02/202422h05Business WireQuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
13/02/202403h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
13/02/202403h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
03/02/202402h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
23/01/202413h00Business WireQuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
22/12/202313h00Business WireQuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QDELQuidelOrtho Corporation
20/12/202322h05Business WireQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR AssayNASDAQ:QDELQuidelOrtho Corporation
08/12/202322h14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
 Showing the most relevant articles for your search:NASDAQ:QDEL

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
TG
TUI1
Tui
NYSE
MRK
Merck
FX
EURUSD
Euro vs US Dollar
CCOM
US500
US 500
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
DBI
SDXP
SDAX
USOTC
RHHBY
Roche (QX)
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
FX
EURGBP
Euro vs Sterling
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten